Vivreon Biosciences' Grant - II Round

Vivreon Biosciences raised a round of funding on August 16, 2017. Investors include National Institute of Aging.

Vivreon Biosciences is a pre-clinical therapeutics company developing a new class of small molecule therapeutics for the treatment of chronic inflammatory diseases. The company's candidate therapies d…

Articles about Vivreon Biosciences' Grant - II Round: